Rolla F. Abu-Arja MD

Pediatric Hematology & Oncology•Columbus, OH

Associate Professor, Pediatrics, Nationwide Children's Hospital/Ohio State University

700 Childrens DrColumbus, OH 43205
Phone+1 614-722-3552
Fax+1 614-722-3699

Dr. Abu-Arja is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abu-Arja's full profile Already have an account?

Summary

Dr. Rolla Abu-Arja is a pediatric hematology and oncology specialist based in Columbus, OH, with expertise in bone marrow transplant. She completed her pediatric residency at mount sinai school of medicine in Jersey city medical center and fellowship at the University of Iowa Hospitals and Clinics after graduating from the University of Jordan Faculty of Medicine. Her research contributions, including publications in journals such as Pediatric Quality & Safety and The Lancet Rheumatology, demonstrate her involvement in improving pediatric blood and marrow transplant programs. Dr. Abu-Arja actively participates in clinical trials as a Principal Investigator, focusing on hematopoietic cell transplantation for various conditions, including hematologic malignancies, myelodysplasia, chronic granulomatous disease, and Wiskott-Aldrich Syndrome.

Education & Training

University of Iowa Health Care Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2008
University of Iowa Health Care Medical CenterResidency, Pediatrics, 2001 - 2004
University of Jordan Faculty of MedicineClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 2011 - 2027
IA State Medical License 2004 - 2015
NJ State Medical License 2002 - 2006
VA State Medical License 2005 - 2006
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02
ENROLLING_BY_INVITATION
Double Cord Versus Haploidentical (BMT CTN 1101)
COMPLETED
PHASE3
Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 Start of enrollment: 2014 Feb 02
COMPLETED

Publications & Presentations

PubMed

When Cure Meets Susceptibility: APOL1 -Associated Kidney Injury After Gene Therapy for Sickle Cell Disease.
Evelyn Gartstein, Lauren McNaughton, O N Ray Bignall, Shamlal Mangray, Anthony Villella
American Journal of Hematology. 2026-09-01
Inclusion of Thiotepa in Myeloablative Regimens Improves Donor Chimerism in Children with Inborn Errors of Immunity or Inherited Metabolic Disorders.
Caitlyn McComb, Vinita Pai, Joseph Stanek, Alexander W Rankin, Margaret Lamb
British Journal of Haematology. 2026-06-01
Current and emerging maintenance strategies after stem cell transplantation in children and adolescents with acute leukemias.
Alexander W Rankin, Amy K Keating, Rolla F Abu-Arja, Monica S Thakar, Hemalatha G Rangarajan
Molecular Therapy. Oncology. 2026-03-19

Abstracts/Posters

Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...
Rolla Abu-Arja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019